Editing Cognitive behavioral therapy (section)

===Side effects===
CBT is generally regarded as having very few if any side effects.<ref>{{Cite web|url=https://www.mayoclinic.org/tests-procedures/cognitive-behavioral-therapy/about/pac-20384610|title=Cognitive behavioral therapy – Mayo Clinic|website=www.mayoclinic.org}}</ref><ref>{{Cite web|title=Ten Things You Need To Know To Overcome OCD|url=https://beyondocd.org/expert-perspectives/articles/ten-things-you-need-to-know-to-overcome-ocd|access-date=2 August 2020|website=Beyond OCD|language=en-US}}</ref> Calls have been made by some for more appraisal of possible side effects of CBT.<ref>{{cite web|url=http://www.nationalelfservice.net/treatment/psychotherapy/psychotherapy-trials-should-report-the-side-effects-of-treatment/|title=Psychotherapy trials should report on the side effects of treatment|date=30 April 2014}}</ref> Many randomized trials of psychological interventions like CBT do not monitor potential harms to the patient.<ref>{{cite journal | vauthors = Jonsson U, Alaie I, Parling T, Arnberg FK | title = Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: a review of current practice | journal = Contemporary Clinical Trials | volume = 38 | issue = 1 | pages = 1–8 | date = May 2014 | pmid = 24607768 | doi = 10.1016/j.cct.2014.02.005 | url = http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-219714 }}</ref> In contrast, randomized trials of pharmacological interventions are much more likely to take adverse effects into consideration.<ref>{{cite journal | vauthors = Vaughan B, Goldstein MH, Alikakos M, Cohen LJ, Serby MJ | title = Frequency of reporting of adverse events in randomized controlled trials of psychotherapy vs. psychopharmacotherapy | journal = Comprehensive Psychiatry | volume = 55 | issue = 4 | pages = 849–855 | date = May 2014 | pmid = 24630200 | pmc = 4346151 | doi = 10.1016/j.comppsych.2014.01.001 }}</ref>

A 2017 meta-analysis revealed that adverse events are not common in children receiving CBT and, furthermore, that CBT is associated with fewer dropouts than either placebo or medications.<ref>{{cite journal | vauthors = Wang Z, Whiteside SP, Sim L, Farah W, Morrow AS, Alsawas M, Barrionuevo P, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Larrea-Mantilla L, Ponce OJ, LeBlanc A, Prokop LJ, Murad MH | display-authors = 6 | title = Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis | journal = JAMA Pediatrics | volume = 171 | issue = 11 | pages = 1049–1056 | date = November 2017 | pmid = 28859190 | pmc = 5710373 | doi = 10.1001/jamapediatrics.2017.3036 }}</ref> Nevertheless, CBT therapists do sometimes report 'unwanted events' and side effects in their outpatients with "negative wellbeing/distress" being the most frequent.<ref>{{Cite journal|date=1 June 2018|title=Unwanted Events and Side Effects in Cognitive Behavior Therapy|journal=Cognitive Therapy |volume=42 |issue=3 |pages=219–229 |doi=10.1007/s10608-018-9904-y |s2cid=44034271 |issn=1573-2819| vauthors = Schermuly-Haupt ML, Linden M, Rush AJ }}</ref>